Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Changes in 5-HT4 receptor and 5-HT transporter binding in olfactory bulbectomized and glucocorticoid receptor heterozygous mice.

Licht CL, Kirkegaard L, Zueger M, Chourbaji S, Gass P, Aznar S, Knudsen GM.

Neurochem Int. 2010 Mar;56(4):603-10. doi: 10.1016/j.neuint.2010.01.003. Epub 2010 Jan 11.

PMID:
20060867
2.

Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter.

Fabre V, Beaufour C, Evrard A, Rioux A, Hanoun N, Lesch KP, Murphy DL, Lanfumey L, Hamon M, Martres MP.

Eur J Neurosci. 2000 Jul;12(7):2299-310.

PMID:
10947809
3.

Olfactory bulbectomy in mice leads to increased BDNF levels and decreased serotonin turnover in depression-related brain areas.

Hellweg R, Zueger M, Fink K, Hörtnagl H, Gass P.

Neurobiol Dis. 2007 Jan;25(1):1-7. Epub 2006 Sep 20.

PMID:
16990008
4.

The brain 5-HT4 receptor binding is down-regulated in the Flinders Sensitive Line depression model and in response to paroxetine administration.

Licht CL, Marcussen AB, Wegener G, Overstreet DH, Aznar S, Knudsen GM.

J Neurochem. 2009 Jun;109(5):1363-74. doi: 10.1111/j.1471-4159.2009.06050.x. Epub 2009 Mar 23.

5.
6.
7.

Serotonin transporter in substance P (neurokinin 1) receptor knock-out mice.

David DJ, Froger N, Guiard B, Przybylski C, Jego G, Boni C, Hunt SP, De Felipe C, Hamon M, Jacquot C, Gardier AM, Lanfumey L.

Eur J Pharmacol. 2004 May 10;492(1):41-8.

PMID:
15145704
8.

Adaptive changes in serotonin neurons of the raphe nuclei in 5-HT(4) receptor knock-out mouse.

Conductier G, Dusticier N, Lucas G, Côté F, Debonnel G, Daszuta A, Dumuis A, Nieoullon A, Hen R, Bockaert J, Compan V.

Eur J Neurosci. 2006 Aug;24(4):1053-62.

PMID:
16930432
9.

Functional consequences of 5-HT transporter gene disruption on 5-HT(1a) receptor-mediated regulation of dorsal raphe and hippocampal cell activity.

Mannoury la Cour C, Boni C, Hanoun N, Lesch KP, Hamon M, Lanfumey L.

J Neurosci. 2001 Mar 15;21(6):2178-85.

10.

Mapping of serotonin 5-HT(4) receptor mRNA and ligand binding sites in the post-mortem human brain.

Bonaventure P, Hall H, Gommeren W, Cras P, Langlois X, Jurzak M, Leysen JE.

Synapse. 2000 Apr;36(1):35-46.

PMID:
10700024
11.

Corticosterone regulation of serotonin transporter and 5-HT1A receptor expression in the aging brain.

Maines LW, Keck BJ, Smith JE, Lakoski JM.

Synapse. 1999 Apr;32(1):58-66.

PMID:
10188639
12.

Genetic variation in 5-hydroxytryptamine transporter expression causes adaptive changes in 5-HT₄ receptor levels.

Jennings KA, Licht CL, Bruce A, Lesch KP, Knudsen GM, Sharp T.

Int J Neuropsychopharmacol. 2012 Sep;15(8):1099-107. doi: 10.1017/S1461145711001258. Epub 2011 Aug 16.

PMID:
21846421
14.

Early life blockade of 5-hydroxytryptamine 1A receptors normalizes sleep and depression-like behavior in adult knock-out mice lacking the serotonin transporter.

Alexandre C, Popa D, Fabre V, Bouali S, Venault P, Lesch KP, Hamon M, Adrien J.

J Neurosci. 2006 May 17;26(20):5554-64.

15.

Reduction of 5-hydroxytryptamine (5-HT)(1A)-mediated temperature and neuroendocrine responses and 5-HT(1A) binding sites in 5-HT transporter knockout mice.

Li Q, Wichems C, Heils A, Van De Kar LD, Lesch KP, Murphy DL.

J Pharmacol Exp Ther. 1999 Dec;291(3):999-1007.

16.

Central 5-HT(1) and 5-HT(2) binding sites in transgenic mice with reduced glucocorticoid receptor number.

Farisse J, Héry F, Barden N, Héry M, Boulenguez P.

Brain Res. 2000 Apr 17;862(1-2):145-53.

PMID:
10799679
17.

Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.

Deltheil T, Guiard BP, Cerdan J, David DJ, Tanaka KF, Repérant C, Guilloux JP, Coudoré F, Hen R, Gardier AM.

Neuropharmacology. 2008 Nov;55(6):1006-14. doi: 10.1016/j.neuropharm.2008.08.001. Epub 2008 Aug 12. Review.

PMID:
18761360
18.

Regional brain serotonin synthesis is increased in the olfactory bulbectomy rat model of depression: an autoradiographic study.

Watanabe A, Tohyama Y, Nguyen KQ, Hasegawa S, Debonnel G, Diksic M.

J Neurochem. 2003 Apr;85(2):469-75.

19.

Monoaminergic compensation in the neuropeptide Y deficient mouse brain.

Gehlert DR, Thompson LK, Hemrick-Luecke SK, Shaw J.

Neuropeptides. 2008 Jun;42(3):367-75. doi: 10.1016/j.npep.2007.10.005. Epub 2008 Mar 7.

PMID:
18329096
20.

Effects of chronic paroxetine treatment on dialysate serotonin in 5-HT1B receptor knockout mice.

Gardier AM, David DJ, Jego G, Przybylski C, Jacquot C, Durier S, Gruwez B, Douvier E, Beauverie P, Poisson N, Hen R, Bourin M.

J Neurochem. 2003 Jul;86(1):13-24.

Supplemental Content

Support Center